在多发性硬化症中使用ocrelizumab:在不断变化的治疗场景中的真实世界经验
Lorena Lorefice1, Paolo Mellino2, Jessica Frau2
1Multiple Sclerosis Center, Department of Medical Sciences and Public Health, University of Cagliari, via Is Guadazzonis 2, 09126, Cagliari, Italy. lorena.lorefice@hotmail.it.
奥克雷利祖马布 (OCR) 对多发性硬化症 (MS) 有效,在复发性复发性MS中显示高NEDA-3率,在初级进展性MS中表现良好. 年轻的年龄和之前的复发率预测了对OCR治疗的更好的反应.
科学领域:
- 神经免疫学 神经免疫学
- 临床神经学 临床神经学
- 药理学研究 药理学研究
背景情况:
- 降低CD20的疗法代表了多发性硬化症 (MS) 治疗的重大进展.
- 奥克雷利祖马布 (OCR) 是针对B细胞的关键疗法,用于MS治疗.
研究的目的:
- 评估ocrelizumab (OCR) 在患有原发性进展性 (PP) 和复发性缓解性 (RR) 多发性硬化症 (MS) 的患者中的利用和有效性.
- 确定MS患者对OCR治疗反应的预测因素.
主要方法:
- 在2017年至2022年期间,对421名多发性硬化症患者进行了OCR治疗的回顾性分析.
- 评估患者在基线和24个月后的特征,以确定没有疾病活动-3 (NEDA-3) 状态的证据.
主要成果:
- 奥克雷利祖马布 (OCR) 的使用呈现越来越大的趋势.
- 观察到高NEDA-3率:84.9%的RRMS和56%的PPMS患者在24个月.
- 年龄较小和较低的前年复发率是治疗反应的重要预测因素.
结论:
- 奥克雷利祖马布 (OCR) 在PPMS和RRMS患者中都显示出高疗效.
- 对于从纳塔利祖马布转换的患者来说,OCR是一种有效的治疗选择和可行的替代方案.
更多相关视频
10:46A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
08:18A Protocol for the Use of Remotely-Supervised Transcranial Direct Current Stimulation tDCS in Multiple Sclerosis MS
Published on: December 26, 2015
相关概念视频
Direct-Acting Cholinergic Agonists: Therapeutic Uses
Cholinergic Antagonists: Therapeutic Uses
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Clinical Trials: Overview
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
